Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
London pre-open: Stocks seen down as attention turns to data points
(Sharecast News) - London stocks were set to fall at the open on Monday as investors looked ahead to key economic data points during the week. The FTSE 100 was called to open down around 20 points.
Ipek Ozkardeskaya, senior analyst at Swissquote Bank, said: "This week, investors' attention will gently shift from earnings to economic data. At this point, the US economy has been resilient and the latest uptick in the CPI data helped investors understand that the Fed will not be cutting its rates any time before summer. The first Fed cut expectation is seen coming by June, with a little less than 70% probability and the Fed is seen cutting the rates by 80bp this year.
"Also due this week, the latest US GDP update - due Wednesday - is expected to confirm a 3.3% growth in Q4, with significantly lower price index. And on Thursday, the PCE data are expected to confirm relatively soft figures - softer than the CPI, most probably thanks to the different weights that the index attributes to different categories of goods and services.
"In all cases, a strong growth could revive the goldilocks optimism if inflation numbers continue to trend lower. For the market rally to continue, we just need strong growth and soft inflation data from the US. Easy, no?"
In UK corporate news, distribution specialist Bunzl posted a 10% rise in annual profits, lifted its dividend and maintained 2024 profits guidance despite a dip in revenue as inflation started to ease.
Pre-tax profit for 2023 came in at £698.6m on revenue of £11.8bn, down 2%. Shareholders will receive 68.3p a share.
The acquisition-hungry group also announced two more purchases - an 80% stake in UK-based Nisbets for £338m and Pamark in Finland for an undisclosed sum.
GSK reported positive results from its trial for gepotidacin, an oral antibiotic aimed at treating uncomplicated urogenital gonorrhoea in adolescents and adults.
Gepotidacin demonstrated non-inferiority to the current leading combination treatment regimen, intramuscular ceftriaxone plus oral azithromycin, meeting the primary efficacy endpoint based on microbiological response at the test-of-cure visit.
It said the results were crucial given the rising rates of gonorrhoea globally, with implications for sexual and reproductive health, adding that it planned to share detailed findings with health authorities while continuing development for other indications, including uncomplicated urinary tract infections.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.